This is a past event
Patient-directed digital healthcare delivery is becoming increasingly prominent and has received impetus from the recent COVID pandemic. Patient-directed digital healthcare is viewed positively by policy makers as a means to increase healthcare access, reduce costs and increase efficiency. Patient-directed digital healthcare also appears to be popular with certain patient groups. Despite this, there are long-standing concerns about digital healthcare adherence, and the true implications of digital healthcare on equity and health outcomes are uncertain. In this talk we will describe the development and piloting of ASICA, a patient-directed digital healthcare intervention to support survivors of melanoma skin cancer. The results of the randomized pilot evaluation with 240 melanoma survivors will be presented to prompt discussion on methods to optimize patient-directed digital healthcare for maximum patient benefit.
- Speaker
- Professor Peter Murchie
- Venue
- Meston 2 and MS Teams